Purpose: Here, we investigate the distribution of cattle and human associated SNP lineages in E. coli O157 isolates from Australia and the U.S.A.
Methods: Ninety-eight E. coli O157 isolates (comprising 24 cattle and 25 clinical sources from each country) were screened for the presence of SNPs using a 48-plex Golden Gate assay system which was subsequently used to assign isolates to 11 SNP lineages.
Results: E. coli O157 isolates from both countries largely segregated into different SNP lineages. The predominant SNP lineages observed in the U.S.A. were also present in Australia, albeit at much lower frequencies. In contrast, the predominant SNP lineages in Australia (IVb; 48% and IVcvar; 30%) were not detected in this U.S.A. isolate set. The IVcvar SNP lineage represents a unique variant that appears to be exclusive to Australia. Overall, a significantly (P < 0.05) higher proportion of U.S.A. isolates (72%) belonged to clinically defined SNP lineages than Australian isolates (4%).
Significance: This study supports previous suggestions that very few Australian E. coli O157 isolates belong to the clinical types observed in the United States. The discovery of a new SNP lineage (IVcvar) in Australian isolates suggests that the genotypic diversity of E. coli O157 may differ worldwide. Therefore, development of future genotyping methods would benefit from using a globally sourced E. coli O157 strain set to ensure that maximum genotypic diversity is captured.